ERAS लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 21:00):
Our systems believe the stock currently is undervalued by 0.03% compare to its pairs and should correct upwards.

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers...

Stats
आज की मात्रा	649 385
औसत मात्रा	1.68M
बाजार मूल्य	533.98M
EPS	$-0.230 ( Q1 \| 2024-05-08 )
अगली कमाई की तारीख	( $-0.170 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.45 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00800 (0.39%)

AADI -2.94%

ABCL 1.65%

ABCM 0.04%

ABEO -2.84%

ABIO -1.68%

ABOS 1.64%

ABSI 2.89%

ABUS -2.30%

ABVX -3.53%

ACAD -0.71%

ACER -17.95%

ACET -4.41%

ACGN 1.29%

ACHL -3.00%

ACHV -1.61%

ACIU -1.00%

ACLX 0.13%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.91%

ADGI 0.87%

ADIL 0.54%

ADMA -2.68%

ADPT -0.30%

ADTX -3.47%

ADVM -3.91%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.82%

AGIO -2.10%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.40%

AKRO -2.81%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -2.29%

ALGS -2.41%

ALKS -0.21%

ALLK -9.32%

ALLO -5.87%

ALLR -3.22%

ALNA 3.16%

ALNY 1.95%

ALPN 0.02%

ALPX 0.00%

ALRN -0.33%

ALT -9.65%

ALVR -0.56%

ALXN 0.00%

ALXO -10.96%

ALZN 4.78%

AMRN -0.31%

AMTI -3.13%

ANAB 0.46%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.66%

ANPC -3.15%

APGE -0.91%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.09%

APLT -5.41%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.27%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.90%

ARDS -14.23%

ARDX -0.58%

ARGX -0.73%

ARNA 0.00%

ARPO -0.90%

ARQT -0.52%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.64%

ARWR -1.56%

ASLN -5.04%

ASMB -7.14%

ASND -0.94%

ATAI -1.48%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 2.91%

ATRA -2.21%

ATXI 1.93%

ATXS -1.00%

AUPH -1.17%

AURA 1.17%

AUTL -1.58%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -5.48%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -1.99%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.96%

BCAB 2.30%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.14%

BCRX 1.32%

BCTX 7.65%

BCTXW -16.29%

BCYC 1.10%

BDRX -3.52%

BDTX -0.43%

BEAM 0.49%

BFRA -2.91%

BGNE -2.72%

BIOR -3.40%

BIVI 2.05%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.71%

BMEA -9.88%

BMRN 0.38%

BNOX -2.22%

BNTC -2.11%

BNTX -1.47%

BOLD -8.11%

BOLT 1.31%

BPMC -1.27%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 22.88%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.35%

CADL -1.42%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.21%

CARM 12.17%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.16%

CCCC -5.21%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 6.07%

CELC -4.25%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.96%

CERO -4.50%

CEROW -10.18%

CFRX -27.95%

CGEM -2.62%

CGEN -3.31%

CGON -0.54%

CGTX -5.11%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 2.56%

CINGW 34.95%

CKPT -2.87%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.04%

CLSD 1.02%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -7.50%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -39.08%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.82%

CORT 2.20%

COYA -1.46%

CPRX -0.99%

CRBP -1.88%

CRBU -4.83%

CRDF -1.77%

CRGX 1.28%

CRIS -0.38%

CRNX -5.81%

CRSP 0.93%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -0.65%

CTXR 2.03%

CUE 3.53%

CVAC -2.26%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 10.09%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.99%

CYTO -2.73%

DARE 6.41%

DAWN 0.52%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 34.01%

DNLI -1.43%

DNTH -6.02%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.21%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 8.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.98%

ELOX 7.69%

ELTX -0.88%

ELVN -4.05%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.13%

ENTA -0.49%

ENTO -4.42%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -1.02%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX 0.00%

EXAI -0.57%

EXEL -0.36%

EYEG -0.69%

EYEN 1.48%

EYPT -0.24%

FATE -7.80%

FBIO 0.59%

FBIOP 0.92%

FBLG -14.30%

FBRX -0.04%

FDMT -4.82%

FENC -0.97%

FGEN -5.56%

FHTX 2.10%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.31%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -1.49%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.31%

GHRS -1.59%

GLMD -2.32%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -2.36%

GLYC -10.00%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.92%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -9.46%

GOVX 7.27%

GOVXW -49.04%

GPCR -6.48%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.08%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -1.15%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.57%

HOOK 0.80%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 2.46%

HSTO 0.00%

HUMA 1.32%

HUMAW -0.01%

IBRX -3.78%

ICCC 0.22%

ICPT 0.21%

ICU 16.49%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.94%

IFRX -1.85%

IGMS -0.15%

IKNA 0.30%

IKT 1.42%

IMAB -0.58%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.68%

INAB 0.00%

INBX 0.53%

INCY -0.86%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 3.01%

INO -2.21%

INSM -0.85%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.42%

IONS 0.43%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -2.15%

IRON -2.54%

ISEE 0.38%

ITOS -1.50%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.05%

JANX -4.03%

JAZZ -0.74%

JNCE 0.00%

JSPR -6.10%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.95%

KDNY 0.22%

KMPH -0.34%

KNSA -2.85%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -6.34%

KRTX 0.03%

KRYS -0.90%

KTRA 18.60%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.41%

KYTX -4.46%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.71%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -3.36%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.61%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.61%

LPCN -4.05%

LPTX -1.10%

LQDA -0.33%

LRMR -1.92%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -34.44%

LYRA 2.33%

MACK 0.10%

MBIO -9.32%

MBRX -1.72%

MCRB 1.76%

MDGL -2.70%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.97%

MGX -2.68%

MIRM -1.80%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.79%

MNKD -1.15%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.18%

MORF -3.86%

MREO -5.29%

MRKR 2.68%

MRNA -4.81%

MRNS -4.04%

MRSN -2.61%

MRTX -0.17%

MRUS 0.13%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.15%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.90%

NEXI 2.60%

NGM -1.28%

NGNE -2.03%

NKGN 6.78%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.82%

NLSPW 26.67%

NMRA -1.32%

NMTR -42.97%

NOVN -24.84%

NRBO 12.08%

NRIX -0.34%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.09%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.13%

NTRBW -31.07%

NUVL -2.00%

NVAX -2.22%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.13%

OABIW -10.06%

OBIO -2.48%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -2.21%

OCUP 1.96%

ODT -4.27%

OKYO 1.51%

OLMA -5.29%

OMER -1.28%

OMGA 5.00%

ONCO 5.04%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.44%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -6.75%

PBYI 1.69%

PCSA 0.00%

PCVX -0.33%

PDSB -2.52%

PEPG 0.27%

PGEN -3.04%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.10%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.00%

PRQR -0.01%

PRTA -2.65%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -0.97%

PTCT -0.28%

PTE -0.82%

PTGX -1.76%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.96%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.41%

RCKT -7.76%

REGN -0.70%

RENB -3.42%

REPL -2.61%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.44%

RIGL -3.29%

RLAY -4.67%

RLMD 0.33%

RLYB 0.00%

RNA -0.49%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM 0.00%

RPRX -0.07%

RPTX -2.93%

RUBY 2.70%

RVLP -32.05%

RVMD -1.20%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.58%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.46%

RYTM -6.51%

RYZB 0.02%

RZLT 1.68%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -4.06%

SAVA -0.31%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 0.00%

SCPS 0.00%

SEEL -4.48%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.03%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.07%

SLGL 4.00%

SLN -4.21%

SLNO -4.03%

SLRX 6.04%

SLS -2.58%

SMMT -3.00%

SNDX 0.87%

SNGX -4.52%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.32%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.44%

SRRA 0.00%

SRRK -2.79%

SRZN -2.45%

STAB 0.00%

STOK -5.09%

STRO -2.84%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.29%

SWTX 0.34%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -7.57%

TARS -0.23%

TBPH 0.60%

TCBP 2.73%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.14%

TENX -1.27%

TERN -7.72%

TFFP -3.05%

TGTX -2.97%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -3.09%

TNGX -2.16%

TNXP -6.39%

TNYA -7.02%

TPST 2.87%

TRDA -3.93%

TRVI 1.15%

TRVN 2.92%

TSHA -24.34%

TSVT -2.79%

TTNP -9.27%

TVTX 0.63%

TYRA -7.01%

UBX -2.12%

UNCY -2.43%

URGN -1.00%

UTHR -0.39%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL 0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.74%

VERU 0.79%

VERV -2.96%

VIGL 5.11%

VINC 1.62%

VIR 0.54%

VIRI -1.57%

VIRX 2.40%

VKTX -1.67%

VLON -13.04%

VNDA -2.20%

VOR -2.02%

VRCA -0.07%

VRDN -4.31%

VRNA -1.40%

VRPX 0.38%

VRTX 0.39%

VSTM -3.58%

VTGN -0.45%

VTVT -2.97%

VTYX -0.21%

VXRT -2.90%

VYGR -1.53%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.51%

XBIO 0.93%

XBIT 1.77%

XCUR 3.58%

XENE -2.85%

XERS 2.38%

XFOR 2.62%

XLO 2.00%

XLRN 0.00%

XNCR 0.47%

XOMA -3.57%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.51%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-20	Varney Michael David	Buy	60 000	Stock Option (right to buy)
2024-06-20	Start Valerie Denise Harding	Buy	60 000	Stock Option (right to buy)
2024-06-20	Liu Jean I	Buy	60 000	Stock Option (right to buy)
2024-06-20	Garner Ebun	Buy	160 082	Stock Option (right to buy)
2024-06-20	Morris Shannon	Buy	137 142	Stock Option (right to buy)

INSIDER POWER
94.48
Last 97 transactions
Buy: 51 526 214 \| Sell: 10 940 033

सहसंबंध (AI algo v.1.1b): Undervalued: 0.03% $2.06 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: -0.29 (neutral)

छोटा: -0.56 (weak negative)

Signal:(51.79) Neutral

Erasca, Inc. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Erasca, Inc. सहसंबंध - मुद्रा/वस्त्र

-0.60
( weak negative )

-0.76
( moderate negative )

0.00
( neutral )

0.51
( weak )

0.52
( weak )

-0.30
( neutral )

Erasca, Inc. वित्तीय

Annual	2023
राजस्व:	$0
सकल लाभ:	$-3.73M (0.00 %)
EPS:	$-0.830

FY	2023
राजस्व:	$0
सकल लाभ:	$-3.73M (0.00 %)
EPS:	$-0.830

FY	2022
राजस्व:	$0
सकल लाभ:	$-2.64M (0.00 %)
EPS:	$-1.950

FY	2021
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.790

Financial Reports:

No articles found.

Erasca, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Erasca, Inc.

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company\'s lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.